Literature DB >> 15144122

Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in osteoarthritis.

H Nakamura1, A Shibakawa, M Tanaka, T Kato, K Nishioka.   

Abstract

OBJECTIVES: To determine the response of glucosamine hydrochloride on chondrocytes and synoviocytes in terms of prostaglandin E2 (PGE2), nitric oxide (NO) and matrix metalloproteases (MMPs).
METHODS: Chondrocytes and synoviocytes were prepared from joint specimens of patients who underwent total knee arthroplasty for osteoarthritis (OA). Chondrocytes from patients with femoral neck fracture were served as a normal control. Culture cells were stimulated by 5 ng/ml of IL-1beta and treated with various concentration of glucosamine hydrochloride (from 1 microg/ml to 500 microg/ml). PGE2, NO, MMP-1, MMP-3, and MMP-13 levels were evaluated in the culture supernatant. Further, the expression of COX-2 mRNA was studied by semiquantitative PCR.
RESULTS: With IL-1beta stimulation, the levels of these mediators increased dramatically, except for NO from synoviocytes. After stimulation, levels of these mediators in OA chondrocytes were higher than synoviocytes and normal chondrocytes, and the level of MMP-3 was higher than those of MMP-1 and MMP-13. Glucosamine hydrochloride at a concentration of 100 microg/ml suppressed PGE2 production, and partly suppressed NO production. It also suppressed the production of MMPs from normal chondrocytes and synoviocytes but not from OA chondrocytes.
CONCLUSION: Glucosamine modulates the metabolism of chondrocytes and synoviocytes and its mode of action differs between cells and conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15144122

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  22 in total

1.  Endoplasmic reticulum stress (ER-stress) by 2-deoxy-D-glucose (2DG) reduces cyclooxygenase-2 (COX-2) expression and N-glycosylation and induces a loss of COX-2 activity via a Src kinase-dependent pathway in rabbit articular chondrocytes.

Authors:  Seon-Mi Yu; Song-Ja Kim
Journal:  Exp Mol Med       Date:  2010-11-30       Impact factor: 8.718

2.  Enhanced production of MMP-1, MMP-3, MMP-13, and RANTES by interaction of chondrocytes with autologous T cells.

Authors:  Hiroshi Nakamura; Michiaki Tanaka; Kayo Masuko-Hongo; Kazuo Yudoh; Tomohiro Kato; Moroe Beppu; Kusuki Nishioka
Journal:  Rheumatol Int       Date:  2006-02-09       Impact factor: 2.631

3.  Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study.

Authors:  Elizabeth D Kantor; Xuehong Zhang; Kana Wu; Lisa B Signorello; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2016-07-18       Impact factor: 7.396

4.  Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial.

Authors:  Takayuki Kawasaki; Hisashi Kurosawa; Hiroshi Ikeda; Sung-Gon Kim; Aki Osawa; Yuji Takazawa; Mitsuaki Kubota; Muneaki Ishijima
Journal:  J Bone Miner Metab       Date:  2008-05-11       Impact factor: 2.626

5.  Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for cartilage metabolism in healthy individuals without symptoms of arthritis: A randomized double-blind placebo-controlled clinical study.

Authors:  Akihito Tomonaga; Keita Watanabe; Mitsuhiko Fukagawa; Asahi Suzuki; Mihoko Kurokawa; Isao Nagaoka
Journal:  Exp Ther Med       Date:  2016-06-24       Impact factor: 2.447

6.  Evaluation of the chondroprotective action of N-acetylglucosamine in a rat experimental osteoarthritis model.

Authors:  Daiki Kubomura; Tomoya Ueno; Masanori Yamada; Isao Nagaoka
Journal:  Exp Ther Med       Date:  2017-07-28       Impact factor: 2.447

Review 7.  Chondroitin and glucosamine in the management of osteoarthritis: an update.

Authors:  Yves Henrotin; Cécile Lambert
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

8.  Effects of glucosamine administration on patients with rheumatoid arthritis.

Authors:  Hiroshi Nakamura; Kayo Masuko; Kazuo Yudoh; Tomohiro Kato; Toshikazu Kamada; Tohru Kawahara
Journal:  Rheumatol Int       Date:  2006-09-05       Impact factor: 2.631

9.  Associations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammation.

Authors:  Elizabeth D Kantor; Johanna W Lampe; Sandi L Navarro; Xiaoling Song; Ginger L Milne; Emily White
Journal:  J Altern Complement Med       Date:  2014-04-16       Impact factor: 2.579

Review 10.  Glucosamine hydrochloride for the treatment of osteoarthritis symptoms.

Authors:  Beth Anne Fox; Mary M Stephens
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.